A Clinical Study of HRS-7525 Tablets in Patients With Advanced Prostate Cancer

NCT07711184 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

320

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: HRS-7525 tablets

Sponsor

Jiangsu HengRui Medicine Co., Ltd.